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Abstract 
Objectives: To explore patients’ perceptions and experiences of ‘normality’ and the 
influences on this at three time points post-transplant.  
Methods: In-depth interviews with 25 patients at three months, one year and more than three 
years following kidney transplant.  Patients’ accounts were compared with Sanderson et al’s 
typology of types of normality.  
Findings: Post transplant, patients worked hard to re-establish normality, albeit in a ‘reset’ 
form.  This normality was a very personal construct, shaped by a wide range of factors 
including age, gender and personal circumstances. Some patients encountered significant 
challenges in regaining normality, both at three months for those experiencing acute and 
distressing side effects, and later relating to the long term side effects of transplant 
medication and co-morbidities. However, the most dramatic threat to normality (disrupted 
normality) came from episodes of rejection and transplant failure. 
Conclusions: The main forms of normality achieved varies for different conditions. Moreover 
despite improvements in health post-transplant and opportunities to build a new, reset 
normality, the participants recognised the need to pay careful attention to the spectre of future 
ill health and transplant failure.  Transplant failure was therefore a source of disruption that 
was central to their illness narratives and perceived as an ever present risk 
Key words: kidney transplantation; patient experience, normality, shifting perspectives, 
adherence to medication, qualitative
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Working to establish ‘normality’ post-transplant: A qualitative study of kidney 
transplant patients 
Introduction 
In popular discourse transplant is presented as a cure. However, few studies have explored 
patients’ perceptions of wellness post-transplant and how these perceptions may change over 
time.  Patient narratives are considered to offer a powerful tool for understanding biomedical 
reality in terms of illness experience and its social and cultural context (1-5).  The 
specificities of kidney transplantation pose something of a problem for a narrative approach 
to analyzing patients’ experiences after the transplant. Were there to be a complete transition 
to health, then transplantation might be considered an epilogue to a previous narrative, and 
the object of study would be this transition to health. However, as Crowley-Matoka et al 
observe, it is critical that we examine the ‘versions of health offered up by biomedicine and 
its interventions.’ (6, 2005:831)  Post transplant experience relates not only to a past of 
illness, but also to a present where there are side-effects to contend with, where illness may 
still obtrude, and to a future where there is the possibility that the transplant may fail; the 
illness narrative of the transplant patient is never finished, even amongst the most successful 
of transplant patients.   
A review of the quantitative literature on quality of life post-transplant concluded that there 
are distinct quality of life benefits associated with kidney transplant, but that further work is 
required to fully understand patients’ experiences of wellness and attempts to regain 
normality (7). The agency of patients with chronic illness in actively adjusting to changes in 
their body, self and the world around them to establish a form of wellness has been 
documented (8). O’Neal (9) suggests that normalization can be seen as an approach to coping 
with chronic illness.  Normalization turns the lens upon the patient and emphasises their 
individual efforts and agency in living with their illness. Sanderson and colleagues (10) argue 
that the complexity of normality has been under-explored in the literature. To address this, 
they draw on a study of rheumatoid arthritis patients at a single point in time to identify six 
types of normality: disrupted, struggling to maintain, fluctuating, resetting, returning and 
continuing normality. (see Table 1) Given the popular discourse around transplant, we might 
expect patients to reach the stage of returning normality following transplant surgery. This 
study provided an opportunity to explore types of normality within a different patient group 
(kidney transplant patients), interviewed at three time points post-transplant. 
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Methods 
Design: Semi-structured interviews were conducted with kidney transplant recipients at three 
time points (three months, one year and three years or more following transplant), with this 
selection of time points being informed by discussions with the clinical team as presenting 
the patient with different issues of adjustment. The first three months following the transplant 
often involves movement from one demanding regime (dialysis) to another, requiring 
considerable adjustment emotionally as well as medically, to their new status.  By one year, 
clinic visits are typically less frequent and medication reduced. The three-year period is a 
time when the patient’s medication and their routines for living a post-transplantation life 
have often re-established, and when there is generally a sense of a reduction in the immediate 
danger of rejection and less contact with clinical care teams.  
 
The study was based on adults over the age of 18, with children and adolescents excluded as 
having distinct issues of adjustment and medication. The study only involved recipients of 
organ donations from the deceased as these patients face both greater risks of rejection 
compared with live donors, and experience different obligations and social meanings 
regarding their transplant (11).  
 
Recruitment: Participants were identified from a list provided by members of the clinical 
team at one large UK transplant centre treating patients from a wide geographical area, with 
rural and urban locations. Patients were selected to provide a mix in terms of: age, gender and 
length of time since their transplant. Given the sensitivity of the topic, the transplant unit staff 
checked the list of patients identified for inclusion to confirm that all were well enough to 
participate and a couple of names were removed from the list before contact was made. 
Participants were sent an information sheet that had been reviewed by members of the local 
Kidney Patient Association for acceptability and completeness. This described the purpose of 
the research, what would be required should they wish to be involved, including the time 
implications. It also provided contacts for further information and a reply slip to indicate 
interest in taking part. Participants were then contacted by the researcher by phone to arrange 
and appointment.  
 
The length of the study period meant that it was only possible to follow up a small number of 
individuals at two time points. However, five participants took part in two interviews: three 
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months after transplant and approximately one year post transplant. Five further patients were 
recruited at three months and five patients at one year to achieve data saturation about post 
transplant experience at these time points.  In order to look at long term experiences, 10 
patients were interviewed three or more years post transplant 
 
Interviews: Following participants’ preference two-thirds of the interviews were conducted in 
their homes, a few interviews were conducted in the research teams’ offices which were close 
to but outside the hospital and one interview was conducted at the participant’s place of work 
at his request. Interviewers met with the research team after interviews for debriefing 
sessions. Some of the interviews were conducted by paired interviewers to provide additional 
support when a new interviewer joined the project. All interviews were digitally recorded 
with the participants’ consent.  
 
A topic guide for the interviews was developed in consultation with the local Kidney Patient 
Association and covered the following broad themes: experiences of health prior to the 
transplant, perceptions of  current state of health, medication and side effects, support from 
social networks, effects of the transplant, current feelings about the transplant and the future. 
The final section of the topic guide focused on hobbies and interests to end with a discussion 
of less sensitive issues.  The interviews usually lasted between one and two hours. 
 
Analysis: Interview transcripts were entered into NVivo9. The initial coding was based on 
broad themes that were augmented in the analysis to take account of emerging interpretations. 
Types of normalization were used at this stage to further interrogate the data.  Analysis 
involved a process of constant comparison, with particular emphasis given to deviant cases, 
with the aim of developing an interpretation and explanation.  
 
Ethics:  Research Ethics Committee approval was obtained from the local NHS Trust, 
reference number:  10/H0703/049 
Findings  
Characteristics of participants 
The study group comprised 15 men and 10 women between the ages of 19 and 65.  Twenty 
one of the 25 were dialysis patients prior to transplant (see Table 2).  Approximately half 
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suffered from diabetes. Others had experienced kidney failure for different reasons including 
kidney disease, HIV and as a side effect of medication.   Some participants had been living 
with ill-health (most commonly as a result of diabetes) since childhood, with one participant 
(Peter) estimating that he had been experiencing ill health for over 40 years.  
Those interviewed more than three years post transplant, had received their transplant on 
average 10 years prior to the interview. Five participants (Peter, Debbie, Ali, John and Joe) 
had previous transplants (including two heart and lung transplants, both more than 10 years 
prior to their kidney transplant and three patients with previous kidney transplants). Five 
participants had received simultaneous pancreas–kidney (SPK) transplants (see Table 2). 
Experience prior to transplant  
The interviews began with the patients retelling their pre-transplant stories, with these  stories 
‘setting the scene’ for a discussion of their post transplant experiences.  In most cases, they 
had experienced a long history of ill health prior to transplant, often  describing living with a 
consistent level of poor health, rather like ‘a flu that doesn’t go away,’ accompanied by more 
acute episodes of ill health and hospitalization.  For example, Sophie described the ‘never 
ending’ tiredness she experienced pre transplant. Sara described how her life had been ‘on 
hold’ prior to her transplant. She and her husband had felt unable to plan for the future. She 
observed that she always started sentences with ’once I’ve had the transplant,’ demonstrating 
a high level of expectation with regard to the transplant. Most participants were on dialysis at 
the time of transplant and  described a wide range of health problems (many relating to their 
diabetes) which, combined with the dialysis regime, affected their energy levels and limited 
their ability to fully participate in everyday life.  Even those who spoke in relatively positive 
terms about their experience of dialysis, observed the contrast with their post-transplant 
experience: 
‘On peritoneal dialysis you can’t, although you think you lead a normal life, actually when 
you’re thinking about it, you know, you can’t really do anything heavy.’ (Edward, I year post 
transplant) 
‘So, you know you can’t get away with having a normal life if you’re on dialysis’ (Catherine, 
three years+ post transplant) 
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Accounts of life before the transplant were typically of a disrupted state of normality (10) in 
which overwhelming symptoms made a normal life impossible. Only one participant, David, 
described his pre-transplant life as close to normal. He worked long hours in a senior post and 
enjoyed a busy life.  David had turned down a previous offer of a transplant as he didn’t feel 
‘ill enough’ to need it. 
Three months post-transplant 
The kidney transplant typically represented a major and usually sustained shift in health.  At 
three months most participants were enjoying their first glimpses of normality. They talked 
about a range of aspects of normality including: work, hobbies and interests, caring for / 
supporting others, holidays, socialising and food and drink, and can be viewed as  engaging 
in what Sanderson et al (10) describe as ‘resetting normality’ by embarking on activities 
(some new, some old). It was clear that they took an active role in establishing a sense of 
normality, with this in turn being shaped by their particular life circumstances. For example, 
prior to her transplant, Sara had relied on her husband and mother to look after her small 
children, describing how this made her feel useless. If she took her son to nursery she would 
need to come home and sleep for a couple of hours to recover.  Post-transplant she was able 
to reclaim her role as wife, mother and daughter and  described how she ‘threw herself into 
lots of things’ including taking the children to school and nursery, a university course, driving 
lessons and planning to move house. Often those who hadn’t been too ill (or ill for very long) 
prior to transplant had quite ambitious goals. For example, Henry, whose underlying health 
condition made a return to work unlikely, was planning to start by doing some yoga, then to 
go to the gym, building up to climbing in a few months time.  A couple of participants were 
looking forward to getting back onto the golf course and working back up to a full round.  
This stepped approach to resetting normality was common amongst participants at this stage.  
At three months, participants were still mindful of the fragility of their health and undertook 
activities to maintain wellness. Some highlighted physical reminders of the operation such as 
discomfort walking down stairs. They described how they followed health advice such as 
using sunscreen and staying out of the sun due to the increased risk of skin cancer and were 
also making regular visits to the transplant clinic for monitoring, considering this to be a 
necessary part of the post-transplant regime.  Discussing the clinic visits Edward commented: 
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It’s very important to just make sure that, that, you know, everything is working, working 
right.  I don’t ever see it as a bind or an inconvenience.’ (Edward, one year post transplant) 
In particular, participants talked at length, usually in a very matter of fact way, about the side 
effects they were experiencing due to the high doses of immuno suppressive medication post-
transplant. These included hair loss, weight gain, tremors, sickness, diarrhoea, vivid dreams, 
mood changes and acne.  These side effects, especially physical symptoms such as acne, 
weight gain and hair loss, affected the resetting of normality. David described how he had 
found it impossible to write his daughter’s birthday card because of the tremors.  Women, in 
particular, talked about feeling self conscious about their appearance. In some cases, 
experience of side effects led to disrupted normality. For example, Sophie said that she 
wouldn’t feel comfortable to leave the house until her hair started to grow back. Karen talked 
about her surprise in experiencing what more than one person described as ‘teenage’ mood 
swings and acne: 
‘I never thought about the side effects until I started coming out in spots’ (Karen, three 
months post-transplant) 
However, the most common response to the medication and side effects was to accept them 
as part of the transplant and key to recovery:  
Janet ‘It [the side effects] is a small price to pay for having, what is, I suppose, my life back 
again, isn’t it, to a normal degree’ 
Interviewer ‘Is that how you would describe it then, having your life back again?’ 
Janet ‘Yes and no. I think other people would describe it as that. I wouldn’t because I can’t 
remember back to not being a diabetic, because I was so young when I was diagnosed and 
diabetic for so long,’ (Janet, three months post- transplant) 
Like Janet, other participants’ view of normality was informed by their prior health and their 
(often distant) memory of what it meant to live a normal life. Peter, who had had a previous 
heart and lung transplant, explained that he hadn’t been able to work for some years prior to 
his recent transplant and that wouldn’t change. However, he could engage in some activities 
that hasn’t been possible for years such as going out for a drink with his brothers and having 
a beer while watching the football at home and regarded these as important elements of his 
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prior normality associated with his working life as a builder. As he commented ‘every builder 
likes a pint, and I used to like a pint, but for four years I hadn’t had a drink’ (Peter, three 
months post-transplant).  In resetting normality, participants were flexible about what it 
would mean to live a normal life. Participation in work in particular, often required 
supportive employers and colleagues, changes to duties, increased working from home or 
reduced hours. 
For those patients who had had a simultaneous kidney and pancreas transplant, the end of the 
diabetes dietary and treatment regime was a particularly positive aspect of resetting 
normality. For example, Joseph described how he continued to test his blood each day and 
was constantly surprised by the consistent blood sugar reading.  He also took considerable 
pleasure in going out for a meal and having a glass of wine and whatever he liked from the 
menu.  
Most patients consistently described their health status in positive terms.  However these are 
not accounts of the reestablishment of an objective state of wellness, but rather reflected their 
desire to regain control over their health when and where they can. As Joseph observed: 
‘At the moment you know I feel I can take on the world, but erm, actually the reality of it is 
probably i’ll be knackered by the time dinner comes around.’ (Joseph, three months post 
transplant)  
Not everyone was experiencing improved health three months post transplant.  A small group 
of patients were focusing on ‘keeping going’ and were trying to come to terms with the 
transplant not being a cure. Their lives were on hold and their prior state of disrupted 
normality continued as they waited to see if the transplant would stabilise.  An extreme 
example was David who had been diagnosed with diabetes brought on by the transplant and 
the transplant itself was not doing well. He was experiencing a loss of normality as his 
condition prior to transplant had not interfered with his ability to pursue a normal life, while    
at three months, he had had three bouts of rejection, six biopsies and an additional 
angioplasty procedure.   
‘I knew what I had been given was a chance and then it all started to fall around me, 
gradually, very quickly.  And it took that away, that euphoric feeling of ‘wow, i’ve got a 
chance now.’... And it’s a much, much slower climb back up, than it is to come back down. It 
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is like a freefall down and then God you’ve really got to dig deep to get back to where you 
believe it’s worth it.’ (David, three months) 
One year post transplant 
A small group of patients continued to experience a disrupted sense of normality one year 
post transplant. For David, the promise of the transplant had slipped away by 12 months and 
he was back on dialysis at 12 months. Two other participants had kept their kidney transplant, 
but lost the pancreas.  Others while retaining their transplant were experiencing on-going 
health problems that sometimes acted as a barrier to their attempts to re-establish normality. 
Alan explained that he was still taking a lot of anti-rejection drugs to support the transplant. 
While he felt better than when he was on dialysis and was managing to get to work, he still 
felt very tired. He had negotiated reduced hours and some home working with his employer. 
His wife was taking a greater share of domestic responsibilities. His account was one of 
continued disrupted normality, while he continued to wait for the transplant to stabilize. 
Janet, who had been doing well at three months had experienced 8 episodes of rejection by 12 
months. Her pancreatic transplant had failed and she was still attending the clinic every week.  
She commented on how different this was from her expectations at transplant: 
‘You’re basically told you have the operation, six months later your back at work and all is 
rosy.’ (Janet, follow up interview at one year).  
Janet had moved from attempts at resetting normality at three months, to a disrupted 
normality. She was getting used to being a diabetic again and worried about the likelihood of 
the kidney failing and needing to start dialysis. Her new partner, who was present at the 
second interview, felt that she had gone ‘too far’ in her pursuit of normality following the 
transplant. He observed that she ‘came home and acted normal...she was normal in her eyes.’ 
Janet also commented that the health professionals had implied that she was, in part, 
responsible for the failure of her transplant.  She felt she hadn’t been given sufficient 
guidance about the type of normality she could establish post-transplant. Normal was a 
complicated idea for Janet as she had been ill since childhood and commented at three 
months that she couldn’t remember what it meant to be well and normal.  Her response had 
been to ‘go with the flow, sort of quite relaxed about a lot of things.’ Furthermore, At 33, 
Janet was younger than many other participants and had experienced a lot of changes at home 
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around the time of her transplant, with a relationship ending and meeting a new partner. She 
explained how she liked to go out and have fun with friends, describing how to mark a 
special occasion she had ended up in a night club with a cannula in her arm. While other 
participants mentioned occasionally forgetting to take their medicines, only Janet admitted to 
reducing some of her medication without consulted her doctors because it was making her 
feel sick.  
After twelve months other people described their lives as less dominated by medication and 
hospital visits and often talked about their recovery in terms of their improved ‘energy’ 
levels. At one year, they were more actively engaged in aspects of everyday life: working, 
shopping, cooking, cleaning, supporting others and caring for children, and had either taken 
or were planning holidays and were able to resume previous hobbies and pursue new 
interests.  Karen had moved house and embarked on an ambitious DIY project, before 
returning to work just before her second interview at 12 months.  She commented how she 
hadn’t realised how ill she was until after the transplant when she began to feel so much 
better. Joseph’s description of his ability to help around the house echoed the comments of 
other participants: 
‘I had a bit of a mad purge last weekend. I cut the front lawn, the back lawn, did the 
hoovering and painted the garage door all in one day...I was a bit tired at the end of it, but 
yes I’m really pleased that I can do that sort of thing, which, before the transplant I was 
really limited. I just couldn’t do anything. Even walking up stairs was an effort, it really was.’ 
(Joseph, 12 months follow up interview) 
Participants like Peter who had been ill for longer periods talked about less ambitious goals, 
but nonetheless sought to reset normality by, for example, going out for a drink or going for a 
walk. Sue described an arresting image of her path to recovery, signalling the distance she 
felt she had travelled towards a state of health and normality in which she could take the dog 
for a walk without having to take constant breaks: 
‘But it’s interesting, having started to walk the dog again after the transplant, we’ve got a 
cycle track at the bottom of the road down here, and we used to walk down the cycle track 
and then there’s a big field.  And when I started taking the dog down there after the 
transplant, it’s very interesting, the dog used to stop at all the places I used to sit down, So it 
was like, and I’d walk and think, ‘oh I used to sit down there, I used to sit down there.’  I 
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mean I don’t sit down at all now.  That’s an interesting sort of measure you can see.’  (Sue, 
one year follow up interview) 
However, participants were mindful that the normality they were establishing post transplant 
did not constitute a return to full health.  As Sue observed:  
‘People think when you’ve had the transplant, it’s finished.  You know, you’ve had the 
transplant and now you’re better, you’re perfect.  And, you know, the fact that you’ve 
discovered that actually that isn’t, that isn’t the case, that you can never say, ‘I am well, I am 
now a perfectly fit person,’ because you’re not.’  (Sue, I year post-transplant) 
Three years or more post-transplant 
At three years or more post-transplant most people required far fewer clinic visits  and 
usually received care at their local hospital rather than the transplant centre.  Aisha described 
how, 17 years post-transplant, she takes just 4 tablets a day and visits the clinic once every 
four months.  Medication continued to be described as a necessary evil.  Catherine had 
recently complained to her husband that she was ‘fed up’ with all the medication. However, 
she stressed that one negative comment in eight years ‘wasn’t bad’ and that the medicines 
were part of her lifestyle and something she was used to.  
‘It is always in the back of your mind that it [the transplant] will fail, at times. And I think if 
anything that makes you more inclined to comply with your treatment, comply with your 
medication because at the end of the day if, you know, if you do the utmost that you can and 
you take your medicine and you go to your follow up appointments, then there’s hopefully 
less chance of it failing in the long run.’ (Catherine, three years + post transplant) 
Many of the three years and over group were working.  Some participants, especially men, 
placed particular emphasis on the importance of work for their sense of normality. Ken 
commented: 
‘It gives me a relatively normal way of life...I go to work and everything else.’ (Ken, three 
years+ post transplant) 
Others discussed positive experiences of leading a more normal life post-transplant that were 
not defined by work. These included being able to play an active role in their families and 
looking after themselves, freedom from the burden of regular dialysis, volunteering, pursuing 
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interests and going on holiday. Catherine explained how her transplant had allowed her and 
her husband to have the family they wanted.  
One source of disruption for this group were the long term side effects of the post transplant 
medication, with minor episodes of ill health sometimes quickly becoming serious threats to 
their health requiring hospitalization. They also sometimes needed additional medication and 
occasionally surgery to treat a range of conditions linked with their transplant including 
osteoporosis, cancer, diabetes and neuropathy.   While some described a single episode of 
disruption others listed a number of episodes of poor health. These episodes were described 
in terms linked to disrupted normality rather than fluctuating normality.  Each acted as a 
reminder of the potentially limited life of the transplant: 
‘I was ill 18 months ago and I had to go into [the hospital] because I had a really bad 
infection and naturally then I thought, ‘Oh is this it?’ (Rose, 3+ years post transplant)  
While their accounts demonstrated resilience and positivity, episodes of ill-health often came 
as a serious blow, that disrupted their normality albeit temporarily. Sanderson et al (10) 
observed that disrupted normality presents the biggest challenge for patients in terms of their 
personal identify and self worth.  For example, Sally who had recently had kidney cancer 
talked about the impact this had had on her psychologically, and described feeling very low 
and worried about her own mortality: 
‘And having had cancer in the last 15 months, that’s also an enormous shock to the psyche.  
And I’ve got to get my boy to university.’  (Sally, 3+ years post transplant)  
For transplant patients the psychological challenge presented by episodes of ill health was 
reinforced by the on-going fear of transplant failure that was shared by all participants in the 
study. 
‘I think about my kidney failing all of the time... I don’t think it goes away’ (Teri, female, 3+ 
years post transplant) 
With the spectre of transplant failure and thus the need for further dialysis and another 
transplant, most patients were cautious about embarking upon treatment options (such as 
reductions in steroids) that might jeopardise the kidney.  The patients’ prior experience of 
dialysis shaped their feelings about needing to return to dialysis in the future: 
13 
 
‘It’s all part of the same story. If I were to talk about my transplant, I would almost certainly 
talk about dialysis’ (Joe, male, 3+ years post transplant) 
Discussion 
In a study of pre transplant experience, Sque et al (15) found that patients sought to live as 
‘normal a life’ as possible while they waited for a transplant, although this was constrained 
by symptoms and treatment and the uncertainty of when a transplant might be available. , 
Transplantation is often considered to hold the promise of a return to good health (3), or at 
least of relief from the constraints of living with renal failure.  However, our study of patients 
post transplant showed how notions of normality vary, with participants typically 
representing just two of Sandersons et al’s ‘types of normality,’ (reset and disrupted 
normality) neither of which involved a return to a previous symptom free state of normality. 
Participants worked towards and were prepared to accept  a new form or ‘reset’ normality 
that was aligned with their capacities post-transplant.  with this normality  forming a very 
personal construct that was shaped by their age, gender and life circumstances.  
Achieving reset normality and experiences of disruption varied over time post 
transplant.Three months post transplant most patients saw a glimpse of normality and began 
to take cautious steps towards it. At one year they were bolder in their attempts to reset 
normality, pursuing work, hobbies and holidays.  In the three year plus group most were 
living with a form of reset normality that made room for their illness, medication and 
treatments. However, three types of disruption emerged from the data. For some, particularly 
women, short term side effects post transplant (such as weight gain, hair loss and acne) made 
it particularly difficult to start pursue a more normal life at three months. In the three year 
plus group, long term side effects, (such as cancer) and co-morbidities disrupted the 
normality they had re-established post transplant. However, the biggest source of disruption 
came from episodes of rejection and transplant failure (experienced in both the three months 
and one year groups). Not only is dialysis part of the past experience of many patients, it is 
also conceived of as a threat to future normality. These findings are consistent with an 
Australian study in which transplant patients placed an extremely high value on retaining 
their transplant, tolerating side effects and appearing to rank transplant survival higher than 
life itself (14) and emphasises how illness narratives vary for different chronic conditions. 
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The absence of examples of returning and continuing types of normality reflects a difference 
in the nature of kidney transplant and of rheumatoid arthritis as chronic conditions, where the 
latter can be associated with quite mild symptoms with some potential for a return to full 
health. The absence of struggling and fluctuating normality may also be linked to the 
resilience of this set of patients and their experiences of both ill health and of self 
management.  As Sanderson et al note (10), the typologies of normality represent different 
moral positions. Whereas disrupted normality presented the greatest challenge to self worth 
and identity, our study participants had the capacity, experience and resilience to cope. Those 
offered a chance to reset normality demonstrated powerful agency in rebuilding their 
normality and protecting their health. The role of the patient in actively pursuing a ‘normal 
life’ seems critical to the post-transplant experience.   
Conclusions  
This paper provides insights into how patients experience life after transplantation and the 
importance they place on achieving normality. However application of Sanderson et al’s 
typology to our group of transplant patients indicated that the main forms of normality 
achieved can vary for different conditions, with the absence among this group of post-
transplant patients of what they identified as continuing, struggling and fluctuating normality.  
Instead post-transplant, participants in this study worked hard to re-establish a new form of 
‘reset’ normality. This was  a very personal construct, shaped by age, gender and a range of 
other situational factors.   
While the transplant usually brought opportunities to build a new normality, Thorne et al and 
Patterson’s concept of ‘illness in the background’ (12, 13) helped to explain the ways in 
which participants lived their lives as fully as possible while paying careful attention to the 
spectre of future ill health and transplant failure. They therefore did not lose sight of the 
importance of disease management and emphasised adherence to medication, attending clinic 
appointments, and generally looking after their health.  Patients experienced different threats 
to normality at the three time points, with the most dramatic threat to normality coming from 
episodes of rejection and transplant failure.   
Transplant failure was thus both a real source of disruption and perceived as an ever present 
risk, with the high value placed on transplant survival and how this influenced their 
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adherence and acceptance of  side effects of medications forming a core feature of 
participants’  illness narratives.  
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Table 1: Types of normality 
 
 
Types of normality 
 
Disrupted normality Symptoms are overwhelming and normal life 
is considered to be impossible   
Resetting normality  Reconceptualising normal life to include the 
illness, symptoms and a changed body and 
self 
Struggling for normality  Emphasis on the struggle to maintain a 
normal life, despite severity of symptoms and 
underlying disruption. Seeking to present a 
normal life to others whatever to cost  
Fluctuating normality Fluctuating and uncontrolled disease activity, 
(characterised in Arthritis by severe and 
frequent flares of inflammation), preventing 
normal life for its duration 
Returning to normality  Normal life is reinstated and symptom free 
Continuing normality  Normal life is unchallenged and symptoms 
are mild and manageable  
Sanderson et al 2011 
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Table 2: Sample characteristics  
Pseudonym Time of interview 
post transplant 
Gender Age Dialysis 
Karen** Three months + one 
year 
Female 41 Yes 
Janet** Three three months 
+ one year 
Female 33 No 
Joseph** three months + one 
year 
Male 48 No 
David three months + one 
year 
Male 40 Yes 
Sue** three months + one 
year 
Female 47 No 
Henry three months  Male 42 Yes 
Sophie three months  Female 52 No 
Peter* three months  Male 58 Yes 
John* three months  Male 47 Yes 
Kofi three months  Male 55 Yes 
Alan one year  Male 47 Yes 
Sara** one year   Female 29 Yes 
Carl one year   Male 53 Yes 
Debbie* one year   Female 42 Yes 
Edward one year  Male 54 Yes 
Geoff  25 years  Male 65 Yes 
Sally Eight years  Female 50 Yes 
Rose Nine years  Female 59 Yes 
Catherine Eight years  Female 40 Yes 
Teri three years  Female 19 Yes 
Ken  12 years  Male 52 Yes 
Jack 24 years  Male 60 Yes 
Joe* eight years  Male 44 Yes 
Ali* seven years  Male 47 Yes 
Steven eight years Male 51 Yes 
*denotes previous transplant operations 
**denotes simultaneous pancreas–kidney transplant  
